Cargando…
Sphingosine 1-Phosphate Modulation in Inflammatory Bowel Diseases: Keeping Lymphocytes Out of the Intestine
Inflammatory bowel diseases (IBDs) are chronic and disabling conditions that, uncontrolled, lead to irreversible bowel damage and associated comorbidities. Despite the new era of biological therapies, IBDs remain not curative. The treatment purpose is to induce endoscopic remission, reduce the progr...
Autores principales: | Dal Buono, Arianna, Gabbiadini, Roberto, Alfarone, Ludovico, Solitano, Virginia, Repici, Alessandro, Vetrano, Stefania, Spinelli, Antonino, Armuzzi, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313037/ https://www.ncbi.nlm.nih.gov/pubmed/35885040 http://dx.doi.org/10.3390/biomedicines10071735 |
Ejemplares similares
-
Fibro-Stenosing Crohn’s Disease: What Is New and What Is Next?
por: Solitano, Virginia, et al.
Publicado: (2023) -
Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the heart of the issue
por: Gabbiadini, Roberto, et al.
Publicado: (2023) -
Technological advances in inflammatory bowel disease endoscopy and histology
por: Alfarone, Ludovico, et al.
Publicado: (2022) -
Critical Appraisal of Filgotinib in the Treatment of Ulcerative Colitis: Current Evidence and Place in Therapy
por: Dal Buono, Arianna, et al.
Publicado: (2022) -
Ileal Pouch–Anal Anastomosis and Pouchitis: The Role of the Microbiota in the Pathogenesis and Therapy
por: Gabbiadini, Roberto, et al.
Publicado: (2022)